166
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate

ORCID Icon, , , , , , , , , , & show all
Pages 1265-1270 | Received 27 Mar 2023, Accepted 23 May 2023, Published online: 10 Jul 2023

References

  • Charpiat B, Bleyzac N, Tod M. Proton pump inhibitors are risk factors for viral infections: even for COVID-19? Clin Drug Investig. 2020 Oct;40(10):897–899. doi: 10.1007/s40261-020-00963-x
  • Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007 Sep;102(9):2047–2056. quiz 2057. doi: 10.1111/j.1572-0241.2007.01275.x
  • Bateman BT, Bykov K, Choudhry NK, et al. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ. 2013 Sep 19;347(sep19 1):f5416. doi: 10.1136/bmj.f5416
  • Homolak J, Kodvanj I, Trkulja V. An additional perspective on proton pump inhibitors as risk factors for COVID-19. Clin Drug Investig. 2021 Mar;41(3):287–289. doi: 10.1007/s40261-021-01007-8
  • Kodvanj I, Homolak J, Trkulja V. People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study. Br J Clin Pharmacol. 2023;89(2):787–831. doi: 10.1111/bcp.15525
  • Yan C, Chen Y, Sun C, et al. Does proton pump inhibitor use lead to a higher risk of coronavirus disease 2019 infection and progression to severe disease? A meta-analysis. Jpn J Infect Dis. 2022 Jan 24;75(1):10–15. doi: 10.7883/yoken.JJID.2021.074
  • Pranata R, Huang I, Lawrensia S, et al. Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis. Pharmacol Rep. 2021 Dec;73(6):1642–1649.
  • World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: World Health Organization. Contract No.: WHO/2019-nCoV/clinical/2020.5. 2020.
  • Lee SW. Regression analysis for continuous independent variables in medical research: statistical standard and guideline of life cycle committee. Life Cycle. 2022;2:e3. doi: 10.54724/lc.2022.e3
  • Lee SW, Acharya KP. Propensity score matching for causal inference and reducing the confounding effects: statistical standard and guideline of life cycle committee. Life Cycle. 2022;2:e18. doi: 10.54724/lc.2022.e18
  • D’Silva KM, Mehta R, Mitchell M, et al. Proton pump inhibitor use and risk for recurrent clostridioides difficile infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Jan 16;27(5):697–703. doi: 10.1016/j.cmi.2021.01.008
  • Mehta P, Nahass RG, Brunetti L. Acid suppression medications during hospitalization as a risk factor for recurrence of Clostridioides difficile infection: systematic review and meta-analysis. Clin Infect Dis. 2021 Jul 1;73(1):e62–e68. doi: 10.1093/cid/ciaa545
  • Busic N, Lucijanic T, Barsic B, et al. Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: differences between vector and mRNA vaccines. J Med Virol. 2022 Jun;94(6):2849–2854.
  • Lucijanic M, Marelic D, Stojic J, et al. Predictors of prolonged hospitalization of COVID-19 patients. Eur Geriatr Med. 2023 Apr 27;14(3):511–516. doi: 10.1007/s41999-023-00787-w

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.